Literature DB >> 2831269

Isolation and characterization of a 14-kDa albumin-binding fragment of streptococcal protein G.

U Sjöbring1, C Falkenberg, E Nielsen, B Akerström, L Björck.   

Abstract

Protein G, a streptococcal cell wall protein, has separate binding sites for human albumin and IgG. Streptococci expressing protein G were treated with the bacteriolytic agent mutanolysin. Several IgG- and human serum albumin (HSA)-binding peptides were identified in the material thus solubilized and one of these, a 14-kDa peptide, was found to bind HSA but not IgG in Western blot experiments. This molecule was purified by affinity chromatography on Sepharose coupled with HSA followed by gel filtration on Sepharose 6B and a final affinity chromatography on IgG-Sepharose, by which low Mr W(15 to 20 kDa)IgG-binding peptides were removed. In different binding experiments the purified 14-kDa peptide bound exclusively HSA and the equilibrium constant between the peptide and HSA was determined to be 3.4 X 10(8) M-1. The relation between the 14-kDa molecule and protein G was studied by analyzing the N-terminal amino acid sequence of the peptide and comparing it with the previously determined protein G sequence. The 40 N-terminal amino acids were found to be identical with an amino acid sequence starting at position 62 in the protein G molecule. These and previous data enabled us to locate the albumin binding to the repetitively arranged domains in the N-terminal half of the protein G molecule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831269

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Cloning and nucleotide sequence of the gene encoding the 136-kilodalton surface protein (muramidase-released protein) of Streptococcus suis type 2.

Authors:  H E Smith; U Vecht; A L Gielkens; M A Smits
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Comparison of albumin receptors expressed on bovine and human group G streptococci.

Authors:  R Raeder; R A Otten; M D Boyle
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

3.  Expression and purification of a truncated recombinant streptococcal protein G.

Authors:  C R Goward; J P Murphy; T Atkinson; D A Barstow
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

Review 4.  Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.

Authors:  W W Navarre; O Schneewind
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

Review 5.  Recent trends in protein and peptide-based biomaterials for advanced drug delivery.

Authors:  Anastasia Varanko; Soumen Saha; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2020-08-29       Impact factor: 15.470

6.  Isolation and molecular characterization of a novel albumin-binding protein from group G streptococci.

Authors:  U Sjöbring
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

Review 7.  Harnessing albumin as a carrier for cancer therapies.

Authors:  Ella N Hoogenboezem; Craig L Duvall
Journal:  Adv Drug Deliv Rev       Date:  2018-07-27       Impact factor: 15.470

Review 8.  Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review.

Authors:  Leen Van de Sande; Sarah Cosyns; Wouter Willaert; Wim Ceelen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

9.  Potential Use for Serosurveillance of Feral Swine to Map Risk for Anthrax Exposure, Texas, USA.

Authors:  Rachel M Maison; Courtney F Pierce; Izabela K Ragan; Vienna R Brown; Michael J Bodenchuk; Richard A Bowen; Angela M Bosco-Lauth
Journal:  Emerg Infect Dis       Date:  2021-12       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.